Targeting Tumor Endothelial Cells with Nanoparticles

Because angiogenesis is a major contributor to cancer progression and metastasis, it is an attractive target for cancer therapy. Although a diverse number of small compounds for anti-angiogenic therapy have been developed, severe adverse effects commonly occur, since small compounds can affect not o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Yu, Akita, Hidetaka, Harashima, Hideyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928777/
https://www.ncbi.nlm.nih.gov/pubmed/31756900
http://dx.doi.org/10.3390/ijms20235819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928777/
https://www.ncbi.nlm.nih.gov/pubmed/31756900
http://dx.doi.org/10.3390/ijms20235819

Ejemplares similares